PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VOOM.DE vs. FNCH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between VOOM.DE and FNCH is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

VOOM.DE vs. FNCH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Lyxor Global Gender Equality (DR) UCITS ETF - Acc (VOOM.DE) and Finch Therapeutics Group, Inc. (FNCH). The values are adjusted to include any dividend payments, if applicable.

0.00%10.00%20.00%30.00%40.00%SeptemberOctoberNovemberDecember2025February
5.87%
42.86%
VOOM.DE
FNCH

Key characteristics

Sharpe Ratio

VOOM.DE:

1.50

FNCH:

2.59

Sortino Ratio

VOOM.DE:

2.12

FNCH:

4.17

Omega Ratio

VOOM.DE:

1.28

FNCH:

1.61

Calmar Ratio

VOOM.DE:

1.58

FNCH:

4.94

Martin Ratio

VOOM.DE:

9.82

FNCH:

15.77

Ulcer Index

VOOM.DE:

1.78%

FNCH:

31.30%

Daily Std Dev

VOOM.DE:

11.66%

FNCH:

190.61%

Max Drawdown

VOOM.DE:

-36.78%

FNCH:

-99.86%

Current Drawdown

VOOM.DE:

-0.11%

FNCH:

-97.60%

Returns By Period

In the year-to-date period, VOOM.DE achieves a 5.52% return, which is significantly lower than FNCH's 36.02% return.


VOOM.DE

YTD

5.52%

1M

4.74%

6M

13.38%

1Y

17.44%

5Y*

7.75%

10Y*

N/A

FNCH

YTD

36.02%

1M

41.01%

6M

52.33%

1Y

483.81%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

VOOM.DE vs. FNCH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VOOM.DE
The Risk-Adjusted Performance Rank of VOOM.DE is 6464
Overall Rank
The Sharpe Ratio Rank of VOOM.DE is 6262
Sharpe Ratio Rank
The Sortino Ratio Rank of VOOM.DE is 6262
Sortino Ratio Rank
The Omega Ratio Rank of VOOM.DE is 6464
Omega Ratio Rank
The Calmar Ratio Rank of VOOM.DE is 5555
Calmar Ratio Rank
The Martin Ratio Rank of VOOM.DE is 7474
Martin Ratio Rank

FNCH
The Risk-Adjusted Performance Rank of FNCH is 9797
Overall Rank
The Sharpe Ratio Rank of FNCH is 9696
Sharpe Ratio Rank
The Sortino Ratio Rank of FNCH is 9797
Sortino Ratio Rank
The Omega Ratio Rank of FNCH is 9797
Omega Ratio Rank
The Calmar Ratio Rank of FNCH is 9898
Calmar Ratio Rank
The Martin Ratio Rank of FNCH is 9696
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

VOOM.DE vs. FNCH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Lyxor Global Gender Equality (DR) UCITS ETF - Acc (VOOM.DE) and Finch Therapeutics Group, Inc. (FNCH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for VOOM.DE, currently valued at 0.92, compared to the broader market0.002.004.000.922.71
The chart of Sortino ratio for VOOM.DE, currently valued at 1.36, compared to the broader market0.005.0010.001.364.24
The chart of Omega ratio for VOOM.DE, currently valued at 1.16, compared to the broader market0.501.001.502.002.503.001.161.63
The chart of Calmar ratio for VOOM.DE, currently valued at 0.72, compared to the broader market0.005.0010.0015.0020.000.725.16
The chart of Martin ratio for VOOM.DE, currently valued at 4.13, compared to the broader market0.0020.0040.0060.0080.00100.00120.004.1316.11
VOOM.DE
FNCH

The current VOOM.DE Sharpe Ratio is 1.50, which is lower than the FNCH Sharpe Ratio of 2.59. The chart below compares the historical Sharpe Ratios of VOOM.DE and FNCH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.501.001.502.002.503.00SeptemberOctoberNovemberDecember2025February
0.92
2.71
VOOM.DE
FNCH

Dividends

VOOM.DE vs. FNCH - Dividend Comparison

Neither VOOM.DE nor FNCH has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

VOOM.DE vs. FNCH - Drawdown Comparison

The maximum VOOM.DE drawdown since its inception was -36.78%, smaller than the maximum FNCH drawdown of -99.86%. Use the drawdown chart below to compare losses from any high point for VOOM.DE and FNCH. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-3.70%
-97.60%
VOOM.DE
FNCH

Volatility

VOOM.DE vs. FNCH - Volatility Comparison

The current volatility for Lyxor Global Gender Equality (DR) UCITS ETF - Acc (VOOM.DE) is 3.12%, while Finch Therapeutics Group, Inc. (FNCH) has a volatility of 25.12%. This indicates that VOOM.DE experiences smaller price fluctuations and is considered to be less risky than FNCH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%SeptemberOctoberNovemberDecember2025February
3.12%
25.12%
VOOM.DE
FNCH
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab